Farnesyl Protein Transferase Inhibition: A Novel Approach to Anti-tumor

E-ISSN： 1875-533x|8|12|1419-1436

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.8, Iss.12, 2001-10, pp. : 1419-1436

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heteronemin as a Protein Farnesyl Transferase Inhibitor

By Ledroit Véronique Debitus Cécile Ausseil Frédéric Raux Roselyne Menou Jean-Louis Hill Bridget

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 42, Iss. 6, 2004-09 ,pp. : 454-456

Informa Healthcare

Access to resources Recommend Favorite

Farnesyl Protein Transferase Inhibitor ZARNESTRA™ R115777 - History of a Discovery

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 10, 2003-06 ,pp. : 1095-1102

Bentham Science Publishers

Access to resources Recommend Favorite

Antagonists of IAP Proteins: Novel Anti-Tumor Agents

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-01 ,pp. : 3877-3892

Bentham Science Publishers

Access to resources Recommend Favorite

Statins-Mediated Inhibition of Rho GTPases as a Potential Tool in Anti-Tumor Therapy

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 6, 2008-06 ,pp. : 609-618

Bentham Science Publishers

Access to resources Recommend Favorite

Farnesyl transferase inhibitors in clinical development

By Caponigro Francesco Casale Marina Bryce Jane

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 6, 2003-06 ,pp. : 943-954

Informa Healthcare

Access to resources Recommend Favorite